American Type Culture Collection (ATCC) Logo American Type Culture Collection (ATCC) Logo Cart 0
  • Careers
  • Support
A scientist using a multichannel pipette to transfer liquid into a microtiter plate with monocytes background.

ATCC is exhibiting at the American Association for Cancer Research® (AACR) Annual Meeting 2026

San Diego Convention Center, San Diego, California

April 17, 2026 - April 22, 2026

Join ATCC at booth #4347 at the meeting and attend our Exhibitor Spotlight Theater and poster presentations to learn how our patient-derived organoids, advanced cell models, and reporter-labeled models can help streamline your assays and enhance your oncology studies. Please feel free to contact us if you have any questions about our innovative cell models.

*Not affiliated with or endorsed by AACR.


Contact us


Join our Exhibitor Spotlight Theater

ATCC’s Advanced Human-Relevant Cancer Models: Enabling the Next Era of Precision Medicine
Presenters:
Carolina Lucchesi, PhD, Principal Scientist, Head of Microphysiological Systems, ATCC
Claudia K. Petritsch, PhD, Associate Professor in Research, Director Pediatric Cancer Model Development Center, Sr. Scientist in Neuroscience, Stanford University
Benjamin David Hopkins, PhD, Weill Cornell Medical College

Date: Monday, April 20, 2026
Time: 12:30 – 1:30 PM
Location: Theater D

Add to your itinerary


This Exhibitor Spotlight Theater is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Spotlight Theater are the opinions of the presenter and do not represent the position or the opinion of the American Association for Cancer Research® (AACR) or its members.

Check out our posters

Patient-derived breast and melanoma circulating tumor cell (CTC) in vitro models as encouraging new tools for cancer research
Presenter: Fang Tian, PhD, Director, Biological Content, ATCC
Date & Time: April 19 from 2:00 PM – 5:00 PM
Poster Number: 1087

Add to your itinerary

Evaluation of ex vivo CAR-T cell cytotoxicity and infiltration using multimodal 2-D and 3-D imaging approaches
Presenter: Catherine McManus, PhD, Cell Biology R&D, ATCC
Date & Time: April 20 from 2:00 PM – 5:00 PM
Poster Number: 3723

Add to your itinerary

ATCC’s patient-derived 2-D & 3-D cancer models make translational oncology a reality for the scientific community
Presenter: Carolina Lucchesi, PhD, Principal Scientist, ATCC
Date & Time: April 20 from 2:00 PM – 5:00 PM
Poster Number: 3405

Add to your itinerary

Immune signaling reporter cell lines enable quantitative monitoring of crosstalk among cancer, innate, and adaptive immune cells in tumor microenvironment model
Presenters: Hyeyoun Chang, PhD, Senior Scientist, ATCC and John Foulke, MS, Lead Biologist, ATCC
Date & Time: April 21 from 9:00 AM – 12:00 PM
Poster Number: 4928

Add to your itinerary

Patient-derived pediatric glioblastoma models provide key insights into IDH1-driven drug resistance
Presenter: Abhay Andar, PhD, Lead Scientist, ATCC
Date & Time: April 21 from 2:00 PM – 5:00 PM
Poster Number: 6171

Add to your itinerary

From tumor to model: Transcriptomic and therapeutic insights from patient-derived colorectal cancer organoids
Presenter: Ajeet Singh, PhD, Senior Scientist, ATCC
Date & Time: April 21 from 2:00 PM – 5:00 PM
Poster Number: 5457

Add to your itinerary

GAS-Luc2 reporter cell lines enable sensitive detection of interferon-gamma signaling for immune activation and CAR-T evaluation across 2D and 3D systems
Presenter: Hyeyoun Chang, PhD, Senior Scientist, ATCC
Date & Time: April 22 from 9:00 AM – 12:00 PM
Poster Number: 6957

Add to your itinerary

Engineering isogenic models harboring resistance mechanisms to the latest-generation EGFR inhibitor in non-small cell lung cancer
Presenter: Fang Tian, PhD, Director, Biological Content, ATCC
Date & Time: April 22 from 9:00 AM – 12:00 PM
Poster Number: 7029

Add to your itinerary

RNA-seq analysis confirms post-thaw transcriptomic stability in ThawReady™ THP-1 assay-ready cells
Presenter: Ajeet Singh, PhD, Senior Scientist, ATCC
Date & Time: April 22 from 9:00 AM – 12:00 PM
Poster Number: 7346

Add to your itinerary

Discover patient-derived cancer models

HCMI cell models

We are continually adding 2-D and 3-D patient-derived cancer models to our portfolio. These next-generation models include both common as well as rare and understudied examples of cancer from numerous tissues.

Explore the collection

Organoids made easy

ATCC Organoid Growth Kits make it easy to subculture and grow your patient-derived organoids. Simply add the contents of the kit into your basal medium and conditioned medium, and you’re ready to feed your organoids!

Start Culturing

Download a PDF of our featured literature

ELISA plate to measure OD with microplate reader. Microtiter plate (96 well) reader for biochemistry analysis. Brochure

ThawReady™ Assay Ready Cells

Eliminate lengthy cell expansion protocols with ThawReady™ Assay Ready Cells. Go from frozen to data in one day!

More
AK-240911-ATCC-cGMP-027-HR.jpg Brochure

The Media Behind Our Leading Cell Lines

Our high-performance media are expertly designed to support the recovery, expansion, cryopreservation, and distribution of ATCC cell lines, virtually guaranteeing successful cell culture every time you thaw a frozen vial of cells.

More
Green and blue organoid cells. Brochure

Human Cancer Models Initiative (HCMI)

ATCC offers a growing collection of models generated by the HCMI, which will include both common as well as rare and understudied examples of cancer from numerous tissues

More
Green and blue NuLi lung epithelial small airway cells. Brochure

hTERT-immortalized Primary Cells

Enjoy the best of all worlds with human telomerase reverse transcriptase (hTERT)-immortalized Primary Cells from ATCC.

More
Blue and black cells. Brochure

Cell Lines by Gene Mutation

This guide organizes our ATCC tumor cell lines according to gene of interest and provides information for each line about the specific mutation.

More
A bright-blue, fluorescent, DAPI stain sphere with a black background. Brochure

Isogenic Cell Lines

With genome editing tools such as CRISPR/Cas9, ATCC has created isogenic cell lines with mutants of key oncogenes, which are ideal for identifying novel, personalized treatment regimens. Explore our resources.

More
Pink and red HGF atubulin 2 hepatocyte line. Brochure

Tumor/Normal Matched Cell Line Pairs

Tumor-derived cell lines matched to either normal or metastatic cell lines obtained from the same patient provide a valuable resource for cancer studies.

More
Purple DNA Brochure

ATCC Cell Line Land

Learn about ATCC Cell Line Land—a curated, ISO 9000-compliant database of RNA-seq and whole-exome sequencing datasets derived from ATCC’s authenticated human and mouse cell lines.

More
Close-up of pipette of drops of clear red media falling into wells culture plate, ripples on the surface of the media. Brochure

Primary Cell Solutions

ATCC Primary Cell Solutions is a system of matched components designed to boost growth, maximize functionality, and maintain normal morphology for each primary cell type.

More

Contact us today

Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.



We will not share your information outside of our distributors network and solely use it to send relevant communications.
Your form was successfully submitted